PL1761492T3 - Szczawian 1-benzylo-4-[(5,6-dimetoksy-1-indanon)-2-ylo]metylopiperydyny (szczawian donepezilu) i jego polimorfy - Google Patents
Szczawian 1-benzylo-4-[(5,6-dimetoksy-1-indanon)-2-ylo]metylopiperydyny (szczawian donepezilu) i jego polimorfyInfo
- Publication number
- PL1761492T3 PL1761492T3 PL04806734T PL04806734T PL1761492T3 PL 1761492 T3 PL1761492 T3 PL 1761492T3 PL 04806734 T PL04806734 T PL 04806734T PL 04806734 T PL04806734 T PL 04806734T PL 1761492 T3 PL1761492 T3 PL 1761492T3
- Authority
- PL
- Poland
- Prior art keywords
- oxalate
- indanone
- dimethoxy
- benzyl
- polymorphs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/879,816 US7439365B2 (en) | 2003-11-17 | 2004-06-29 | Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil) |
EP04806734A EP1761492B1 (en) | 2004-06-29 | 2004-07-22 | 1-benzyl-4-¬(5,6-dimethoxy-1-indanone)-2-yl methyl piperidine oxalate (donepezil oxalate) and its polymorphs |
PCT/IN2004/000220 WO2006001031A1 (en) | 2004-06-29 | 2004-07-22 | 1-benzyl-4- ` (5,6-dimethoxy-1-indanone)-2-yl! methyl piperidine oxalate (donepezil oxalate) and its polymorphs |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1761492T3 true PL1761492T3 (pl) | 2010-05-31 |
Family
ID=34959819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04806734T PL1761492T3 (pl) | 2004-06-29 | 2004-07-22 | Szczawian 1-benzylo-4-[(5,6-dimetoksy-1-indanon)-2-ylo]metylopiperydyny (szczawian donepezilu) i jego polimorfy |
Country Status (15)
Country | Link |
---|---|
US (1) | US7439365B2 (pl) |
EP (1) | EP1761492B1 (pl) |
JP (1) | JP2007536209A (pl) |
KR (1) | KR20060090245A (pl) |
CN (1) | CN1874998A (pl) |
AT (1) | ATE448203T1 (pl) |
AU (1) | AU2004320911A1 (pl) |
CA (1) | CA2549752C (pl) |
DE (1) | DE602004024129D1 (pl) |
EA (1) | EA200700150A1 (pl) |
ES (1) | ES2336572T3 (pl) |
PL (1) | PL1761492T3 (pl) |
PT (1) | PT1761492E (pl) |
WO (1) | WO2006001031A1 (pl) |
ZA (1) | ZA200602133B (pl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0401850A3 (en) * | 2004-09-15 | 2008-03-28 | Egis Gyogyszergyar Nyilvanosan | Donepezil salts for producing pharmaceutical composition |
DE102004046497A1 (de) * | 2004-09-23 | 2006-04-06 | Helm Ag | Donepezil-Salze |
US7592459B2 (en) * | 2004-09-29 | 2009-09-22 | Chemagis Ltd. | Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
WO2006063025A1 (en) * | 2004-12-07 | 2006-06-15 | Nektar Therapeutics | Stable non-crystalline formulation comprising donepezil |
RU2401125C2 (ru) * | 2004-12-27 | 2010-10-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Способ стабилизации лекарственного средства против деменции |
US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
HU227474B1 (en) * | 2005-12-20 | 2011-07-28 | Richter Gedeon Nyrt | Process for industrial scale production of high purity donepezil hydrochloride polymorph i. |
US20100113793A1 (en) * | 2006-03-20 | 2010-05-06 | Ind-Swift Laboratories Limited | Process for the Preparation of Highly Pure Donepezil |
EP2204364B1 (en) | 2007-09-28 | 2013-03-20 | Tianjin Hemay Bio-Tech Co., Ltd. | Polymorphs of donepezil salts, preparation methods and uses thereof |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
CN102164601A (zh) * | 2008-09-30 | 2011-08-24 | 帝国制药美国公司 | 经皮延长给药多奈哌齐组合物及其使用方法 |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
US20140243278A1 (en) * | 2011-07-05 | 2014-08-28 | Sunil Sadanand Nadkarni | Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof |
CN108976163B (zh) * | 2017-06-05 | 2023-08-11 | 上海奥博生物医药股份有限公司 | 一种多奈哌齐双羟萘酸盐新的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
DK1048653T3 (da) * | 1997-12-05 | 2004-05-24 | Eisai Co Ltd | Donepezilpolykrystaller og fremgangsmåde til fremstilling deraf |
-
2004
- 2004-06-29 US US10/879,816 patent/US7439365B2/en not_active Expired - Fee Related
- 2004-07-22 CA CA2549752A patent/CA2549752C/en not_active Expired - Fee Related
- 2004-07-22 CN CNA2004800318184A patent/CN1874998A/zh active Pending
- 2004-07-22 ES ES04806734T patent/ES2336572T3/es active Active
- 2004-07-22 KR KR1020067006534A patent/KR20060090245A/ko not_active Application Discontinuation
- 2004-07-22 AU AU2004320911A patent/AU2004320911A1/en not_active Abandoned
- 2004-07-22 PT PT04806734T patent/PT1761492E/pt unknown
- 2004-07-22 DE DE602004024129T patent/DE602004024129D1/de active Active
- 2004-07-22 JP JP2006537559A patent/JP2007536209A/ja not_active Withdrawn
- 2004-07-22 EA EA200700150A patent/EA200700150A1/ru unknown
- 2004-07-22 WO PCT/IN2004/000220 patent/WO2006001031A1/en active Application Filing
- 2004-07-22 PL PL04806734T patent/PL1761492T3/pl unknown
- 2004-07-22 EP EP04806734A patent/EP1761492B1/en active Active
- 2004-07-22 AT AT04806734T patent/ATE448203T1/de not_active IP Right Cessation
-
2006
- 2006-03-14 ZA ZA200602133A patent/ZA200602133B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1761492A1 (en) | 2007-03-14 |
AU2004320911A8 (en) | 2008-08-21 |
CA2549752C (en) | 2010-04-13 |
US20050107613A1 (en) | 2005-05-19 |
JP2007536209A (ja) | 2007-12-13 |
CA2549752A1 (en) | 2006-01-05 |
DE602004024129D1 (de) | 2009-12-24 |
EP1761492B1 (en) | 2009-11-11 |
WO2006001031A1 (en) | 2006-01-05 |
EA200700150A1 (ru) | 2007-08-31 |
ES2336572T3 (es) | 2010-04-14 |
US7439365B2 (en) | 2008-10-21 |
ZA200602133B (en) | 2007-06-27 |
ATE448203T1 (de) | 2009-11-15 |
PT1761492E (pt) | 2010-02-18 |
KR20060090245A (ko) | 2006-08-10 |
CN1874998A (zh) | 2006-12-06 |
AU2004320911A1 (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1761492T3 (pl) | Szczawian 1-benzylo-4-[(5,6-dimetoksy-1-indanon)-2-ylo]metylopiperydyny (szczawian donepezilu) i jego polimorfy | |
EA200700673A1 (ru) | Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид | |
IL150509A0 (en) | Pharmaceutical compositions containing donepezil hydrocholoride | |
IL189986A0 (en) | Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine or hydrochloride thereof | |
HK1095327A1 (en) | 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists | |
IL166795A (en) | N - aryl piperidine substituted biphenylcarboxamides, pharmaceutical composiitons comprising them and method for their preparation | |
ATE328879T1 (de) | Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv | |
MX2011005090A (es) | Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)feni l] piperidina. | |
IL178766A0 (en) | Processes for producing 1 - benzyl - 4 - [(5, 6 - dimethoxy - 1indanon) - 2 - yl] methylpiperidine and hydrochloride thereof | |
DE60203481D1 (de) | Piperidinderivate als neurokinin 1 antagonisten | |
HK1090051A1 (en) | 4-(2-phenylsulfanyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors | |
IL163896A0 (en) | Piperidine or 8-aza-bicycloÄ3.2.1Üoct-3-yl derivatives useful as modulators of chemokine receptoractivity (especially ccr5) | |
EP1935884A3 (en) | New crystalline forms of donepezil base | |
WO2007073888A3 (de) | Pharmazeutische zusammensetzung enthaltend donepezilhydrochlorid, tablette hieraus und verfahren zu deren herstellung | |
WO2009118516A8 (en) | Process for the preparation of donepezil hydrochloride | |
NO20035572L (no) | Fremgangsmate til fremstilling av piperidinderivatet fexofenadin | |
IL188916A0 (en) | Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-ylidene]methylpiperidine | |
EP1616861A3 (en) | A process for the preparation of keto compounds | |
SI1531151T1 (sl) | Postopek za pripravo 1-benzil-4-(5,6-dimetoksi-1-indanon)2-il)metil- piperidin.hidroklorida (donepezil.hcl) | |
IL158660A0 (en) | Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same | |
WO2005076749A3 (en) | A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine | |
HUP0201673A3 (en) | Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha, alpha-dimethylbenzeneacetic acid | |
EP1841739B8 (en) | Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or salt thereof via novel intermediate | |
ATE450527T1 (de) | Piperidinderivate als ccr5-inhibitoren | |
PL375163A1 (pl) | Nowe pochodne piperydyny i ich zastosowanie jako inhibitory wychwytu zwrotnego monoaminy |